Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Nithin Kandalam Awarded Best Stylish Icon of Sandalwood by Action Prince Dhruva Sarja Entertainment
  • Latest Report on Indian Commercial Vehicle Market Being Saturated Business
  • Badve Engineering Ltd rebrands as Belrise Industries Ltd Business
  • Havells Illuminates Shri Ram Mandir, Ayodhya with Exquisite Indoor Lighting Business
  • BNI Anthropos –No.1 chapter of the region recently organized one of the largest networking event “UNITY SUMMIT” at the iconic location “Statue of Unity” on 25th August 2023 Business
  • Ace Designer Nidhi Yasha Behind Gadar 2’s Stunning and Historically Accurate Costumes Entertainment
  • From a Rajasthan Village to the Heart of India’s Music Industry, Deepak’s Journey Strikes a Chord Nationwide Lifestyle
  • Expanding its Footprint, Ampath (American Institute of Pathology & Laboratory Sciences) Launches its 2nd Reference Lab in India Technology

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • HART Ring by FITTR: Transforming Health Monitoring Across India Health
  • MGL Aarogya Programme Empowers 2,000 Rural Women in Raigad with Cervical Cancer Awareness and Screening Health
  • QuickVitals Named Finalist in the Australian AI Awards for AI Innovator – Healthcare Health
  • Introducing MOI: India’s only Tens + Heating Device For Period Pain Health
  • How to Stop Hair Fall in Winter: Real Reasons, Real Fixes, No Nonsense Health
  • On India’s 77th Republic Day, Davaindia Launches 77 New Company Stores to Strengthen Affordable Healthcare Health

Recent Posts

  • Ryan Pinto on Building Good Human Beings: Why Value-Based Education Matters in Today’s World
  • CDSL–KPMG in India Report Calls for Data-Led Transformation of India’s Securities Market, Proposes ‘3C’ Framework
  • Dhruv Consultancy Services Secures 6th Position Across India Among 57 Players; Reinforces Execution Strength and Industry Credibility
  • The Popular Story Exclusive: India’s Top 50 Iconic Personalities of 2026 Revealed
  • Dadasaheb Phalke International Film Festival 2026 Announces the TOP 100 Short Films

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • GM Launches New Pedestal Fans ALLURE and New colour series in Odyssey Premier Ceiling Fan Lifestyle
  • Startup Grind Delhi, AngelBlue, Kyaa Matlab Network & Hubhopper celebrate IWD Business
  • Mahendra Realtors & Infrastructure Limited IPO Opens on 12th August, 2025 Business
  • Exhicon Signs Agreement with Butterfly Funtainments to Launch “Messe Global Arena Kharadi” Business
  • Dark Nuns: A Haunting Revival — When Sisters Battle Demons and Box Office Doubts Entertainment
  • Tiigers of Kolkata, led by Aksha Kamboj, win Indian Street Premier League debut Sports
  • bauma CONEXPO India is proud to join hands with the Construction Federation of India (CFI) for its 2024 edition Business
  • Zypp Electric and Gurugram Traffic Police Launch ‘Green Hai Toh Zypp Hai’ Campaign to Promote EV Adoption and Road Safety Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme